University of Copenhagen researchers have developed a prototype patch for treating plaque psoriasis, which may simplify ...

Successful go-public transaction and over $475 million raised this year provides cash runway through multiple clinical ...

Researchers at Case Western Reserve University have identified a new target to treat atherosclerosis, a condition where ...

Researchers at the University of Massachusetts Amherst have invented a new, sprayable delivery system for psoriasis ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis Two trials for active psoriatic arthritis (PsA) with one focusing on ...

Researchers at the University of Copenhagen have developed a patch for easier and more effective treatment of psoriasis. The ...

"This is the first time I'm really talking about it publicly… but you just get that 'aha' moment where you realize 'I wasn't put in this position to not utilize my voice and my platform for good." La ...

MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update Ended the third quarter with $493.9 million in cash, cash equivalents and short-term marketable ...

Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based ...

A recent cohort study suggests physical activity may improve psoriasis severity and cardiovascular health, showing reduced PASI scores and better BP.